UC San Diego Researchers Receive New CIRM Funding
May 25, 2012
…mutations that cause amyotrophic lateral sclerosis and finding new drugs to treat heart failure and Alzheimer’s disease.
Your search for “drug development” returned 1008 results
Unexpected Activity of Two Enzymes Helps Explain Why Liver Cancer Drugs Fail
December 13, 2016
…Cell Reports, provides a new understanding of liver cancer development, new therapeutic approach and new mouse model for studying the disease.
UC San Diego Moores Cancer Center Launches Bold Campaign to Personalize Cancer Treatment
September 17, 2012
…order to match each patient to the best available drug for his or her particular tumor.
Now Showing: Medicinal Chemistry in 3D
January 3, 2020
UC San Diego’s Seth Cohen and his research team, including colleagues at Germany’s Ruhr University Bochum led by Nils Metzler-Nolte, used a new type of metal-based molecular building block to serve as the basis for developing new therapeutic drugs. Their work is published in Chemical Science.
Building Robust Collaborations to ‘ATTACK’ Future Pandemics
January 18, 2022
Six University of California campuses, in coordination with two national labs and more than one dozen industry partners, have formed the University of California-National Labs Antiviral Treatments Targeting All Coronaviruses and Key RNA viruses Consortium to prepare for and prevent future pandemics.
State’s Stem Cell Agency Awards $18.2 Million Grant for B Cell Cancer Clinical Trial
August 24, 2017
The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) today unanimously approved an $18.29 million grant to University of California San Diego School of Medicine researchers to fund a phase Ib/IIa clinical trial of a novel combination drug therapy for B-cell cancers.
Honoring a UC San Diego Landmark and Its Lasting Impact on Physics
September 8, 2022
…and quantum materials were developed. It was also in Mayer Hall where Walter Kohn and Lu Jeu Sham created the Kohn-Sham equation as part of their work in establishing density functional theory, or DFT. Shpyrko concluded that, no, there wasn’t magic inside the walls of Mayer Hall, but there was…
Potential New Drug Class Hits Multiple Cancer Cell Targets, Boosting Efficacy and Safety
February 1, 2017
…biopharmaceutical company, describe a potential new class of anti-cancer drugs that inhibit two or more molecular targets at once, maximizing therapeutic efficiency and safety.
Researchers Evaluate Controversial Treatment for Parkinson’s Disease Psychosis
September 26, 2018
…linked to a new drug for treating Parkinson’s disease psychosis, researchers at University of California San Diego School of Medicine conducted a retrospective study of qualifying patients in the UC San Diego Health system concluding that the new drug, pimavanserin (marketed as Nuplazid), did not pose a statistically significant greater…
Cancer Avatars for Personalized Medicine
May 21, 2014
Researchers at University of California, San Diego School of Medicine and Moores Cancer Center have used computer simulations of cancer cells – cancer avatars – to identify drugs most likely to kill cancer cells isolated from patients’ brain tumors.
